The Canine Osteosarcoma Vaccine, Live Listeria Vector (COV-LLV) study has been completed. Unfortunately, some dogs became infected with Listeria and then put their owners at risk for a Listeria infection. Due to the risks associated with this infectious disease, the USDA shut down the product and deemed it an unsafe product.
We still are working hard to find new solutions to fight bone cancer in dogs. Osteosarcoma remains an aggressive cancer. There are new things on the horizon ranging from a novel vaccine product by Elias, which we hope to offer some time in the near future, to new drugs and drug combinations that can help to slow cancer spread.